ABU DHABI / GULF TIME As the world marks Sarcoma Awareness Month this July, leading ...
Read More »AstraZeneca treatments win orphan FDA status
Bloomberg Two AstraZeneca Plc cancer drugs received orphan status for treatment of liver cancer, a designation that may eventually speed progress to approval. The US Food and Drug Administration (FDA) granted the special status reserved for rare conditions to Imfinzi, a lung cancer treatment, and tremelimumab, which has been tested in a combination in a variety of cancers, AstraZeneca said ...
Read More »